Treatment failure (indication for non‐routine secondary surgery) · adults (aged ≥ 16 years) with acute middle third clavicle fractures
Surgical may leads to lower treatment failuref Indication for non‐routine secondary surgery compared with conservative interventions (low certainty).
1 finding from 1 review
Cosmetic problemi · adults (aged ≥ 16 years) with acute middle third clavicle fractures
It is very uncertain whether surgical changes cosmetic problemi compared with conservative interventions (very low certainty).
1 finding from 1 review
Total of participants with adverse event outcomel · adults (aged ≥ 16 years) with acute middle third clavicle fractures
It is very uncertain whether surgical changes total of participants with adverse event outcomel compared with conservative interventions (very low certainty).
1 finding from 1 review
Health‐related quality of life (physical) · adults (aged ≥ 16 years) with acute middle third clavicle fractures
1 finding from 1 review
Split renal function (SRF; · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
Drainage pattern ( · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
Upper urinary tract dilatation ( · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
UPJO‐associated clinical symptoms · newborns and infants < 2 years of age with unilateral ureteric‐pelvic junction obstruction
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Short‐term mortality All‐cause mortality either in‐hospital or within 3 months · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes short‐term mortality All‐cause mortality either in‐hospital or… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term recurrence (binary outcome) Local recurrence, surgical… compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Long‐term recurrence (maximal · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term recurrence (time‐to‐event outcome) Local recurrence,… compared with surgical treatment of oesophageal cancer (secondary outcomes) (low certainty).
1 finding from 1 review
Local recurrence · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes local recurrence (binary) compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Proportion with any adverse event within 3 months Any adverse event within 3 months of any severity · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes proportion with any adverse event within 3 months Any adverse event… compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Length of hospital stay (days) Including the index admission for oesophagectomy (the hospital admission during which the oesophagectomy is performed) and any surgical complication‐related readmissions · patients with oesophageal cancer
1 finding from 1 review
Dysphagia · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes dysphagia at maximal compared with surgical treatment of oesophageal cancer (secondary outcomes) (very low certainty).
1 finding from 1 review
Long‐term mortality (binary outcome) All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (binary outcome) All‐cause mortality for the… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): chemoradiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
Non‐surgical showed no clear difference in long‐term mortality (time‐to‐event outcome): chemoradiotherapy… compared with surgical treatment of oesophageal cancer (primary outcomes) (low certainty).
2 findings from 1 review
Long‐term mortality (time‐to‐event outcome): radiotherapy versus surgery All‐cause mortality for the duration of · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes long‐term mortality (time‐to‐event outcome): radiotherapy versus… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Proportion of participants with 1 or more serious adverse events according to International Conference on Harmonisation Good Clinical Practice (ICH‐GCP) · patients with oesophageal cancer
It is very uncertain whether non‐surgical changes proportion with a serious adverse event within 3 months Serious… compared with surgical treatment of oesophageal cancer (primary outcomes) (very low certainty).
1 finding from 1 review
Health‐related quality of life Validated self‐reported measures · patients with oesophageal cancer
1 finding from 1 review